H.R. 5853 (112th): Gray Market Drug Reform and Transparency Act of 2012

To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce.

The bill’s titles are written by its sponsor.

Overview

Introduced:

May 22, 2012
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on May 22, 2012, in a previous session of Congress, but was not enacted.

Sponsor:

Elijah Cummings

Representative for Maryland's 7th congressional district

Democrat

Text:

Read Text »
Last Updated: May 22, 2012
Length: 11 pages

History

May 22, 2012
 
Introduced

This is the first step in the legislative process.

H.R. 5853 (112th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not enacted by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012.” www.GovTrack.us. 2012. December 10, 2016 <https://www.govtrack.us/congress/bills/112/hr5853>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.